BÇü°£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø°ú CÇü°£¿°¹ÙÀÌ·¯½º Ç×ü ÇåÇ÷Ç÷¾× ¼±º°°Ë»ç ¼÷·Ãµµ½ÃÇè °á°ú(2012¡­2015³â)
Results of Proficiency Tests for HBsAg and Anti-HCV as the Blood Donor Screening Testing (2012¡­2015)

´ëÇѼöÇ÷ÇÐȸÁö 2016³â 27±Ç 3È£ p.265 ~ p.273

À̹̳²(Lee Mi-Nam) - Áúº´°ü¸®º»ºÎ Ç÷¾×¾ÈÀü°¨½Ã°ú
±èÁسâ(Kim Jun-Nyun) - Áúº´°ü¸®º»ºÎ Ç÷¾×¾ÈÀü°¨½Ã°ú
Â÷¿µÁÖ(Cha Young-Joo) - Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
¹Ú±ÔÀº(Park Qu-Ehn) - ±¹±ºÀÇÇבּ¸¼Ò
±èÇö¿Á(Kim Hyun-Ok) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
±Ç°èö(Kwon Kye-Chul) - Ãæ³²´ëÇб³º´¿ø Áø´Ü°Ë»çÀÇÇаú
ÃÖ¿µ½Ç(Choi Young-Sill) - Áúº´°ü¸®º»ºÎ °¨¿°º´°ü¸®¼¾ÅÍ °¨¿°º´Áø´Ü°ü¸®°ú
±ÇÁ¤¶õ(Kwon Jeong-Ran) - Áúº´°ü¸®º»ºÎ Áúº´¿¹¹æ¼¾ÅÍ °Ç°­¿µ¾çÁ¶»ç°ú

Abstract

Background: Donor screening test is one of the most important processes for blood safety management. Korea Center for Disease Control and Prevention (KCDC) has been conducting an annual proficiency test program that includes the distribution of specially manufactured panels for hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV) to blood centers. Here, KCDC reports the results of these proficiency tests for HBsAg and anti-HCV blood donor screening for all licensed blood centers in Korea between 2012 and 2015.

Methods: Panels for the proficiency tests were manufactured and distributed to blood centers by Chung-Ang University Hospital, which has been participating in the Korea Blood Safety Commission. Well-proven reactive sera and healthy donor¡¯s sera acquired from the Human Serum Bank in Chung-Ang University were used to make the panels. To identify the S/CO ratio of the panel, three medical institutes triple-checked the results of each panel.

Results: Most blood centers reported correct answers for the proficiency test with six panels. The average percentages (year) of correct answers were as follows: 98.7% (2012), 98.5% (2013), 99.1% (2014) and 99.6% (2015) for the HBsAg proficiency tests; and 97.7% (2012), 99.5% (2013), 99.1% (2014), and 99.8% (2015) for the anti-HCV proficiency tests.

Conclusion: To improve the blood center¡¯s ability for donor screening tests, KCDC will continue the proficiency test program by managing specialized panels for HBsAg and Anti-HCV tests. Furthermore, we will investigate the level of satisfaction to improve the quality of the program.

Å°¿öµå

HBsAg, Anti-HCV, Proficiency test, Blood center, Donor screening test
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The average percentages (year) of correct answers were as follows: 98.7% (2012), 98.5% (2013), 99.1% (2014) and 99.6% (2015) for the HBsAg proficiency tests; and 97.7% (2012), 99.5% (2013), 99.1% (2014), and 99.8% (2015) for the anti-HCV proficiency tests.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå